"Liquid Gold" - The unTAPped Potential of Cerebrospinal Fluid Analysis?
editorial · Level V
Where this comes from
- Record sourced from PubMed, PMID 32139404.
- Also identified by DOI 10.1158/1078-0432.CCR-20-0173 and PMC identifier 10664042.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Obtaining blood and cerebrospinal fluid is generally less invasive than standard tumor biopsy, and are increasingly used to develop surrogate biomarkers. Leptomeningeal disease, a devastating complication of cancer, represents a unique opportunity for using liquid biopsies for diagnosis, treatment, and to elucidate underlying mechanisms of resistance to therapy.<i>See related article by Smalley et al., p. 2163</i>.
Medical subject headings
- Lung Neoplasms
- Melanoma